Introducing the RUO Anti-EGFRvIII Antibody (AMG-595) – the revolutionary biotech product that is changing the game in cancer research. This highly specific antibody is designed to target the EGFRvIII protein, a variant of the epidermal growth factor receptor (EGFR) that is commonly expressed in various types of cancer cells.
The biological function of the RUO Anti-EGFRvIII Antibody is to bind to the EGFRvIII protein and block its signaling pathway, which is known to promote tumor growth and resistance to treatment. By inhibiting this pathway, the antibody effectively hinders the growth and survival of cancer cells, making it a promising tool for cancer therapy.
This antibody has a wide range of applications in cancer research, including but not limited to:
1. Targeted therapy for EGFRvIII-positive cancers: The RUO Anti-EGFRvIII Antibody can be used as a targeted therapy for various types of cancer that overexpress the EGFRvIII protein, such as glioblastoma, breast cancer, and lung cancer.
2. Biomarker for EGFRvIII detection: The antibody can also be used as a biomarker to detect the presence of EGFRvIII in cancer cells, allowing for early diagnosis and personalized treatment.
3. Combination therapy: The RUO Anti-EGFRvIII Antibody can be combined with other anti-cancer treatments, such as chemotherapy and radiation therapy, to enhance their effectiveness and reduce the risk of resistance.
In addition to these main applications, the RUO Anti-EGFRvIII Antibody has been extensively used in various experimental settings, with promising results. For example, in preclinical studies, the antibody has shown significant anti-tumor activity in EGFRvIII-positive cancer models, both as a monotherapy and in combination with other treatments.
When it comes to cancer research, every detail matters. That’s why the RUO Anti-EGFRvIII Antibody is manufactured with the highest quality standards and rigorously tested to ensure its specificity and potency. This product is intended for research use only (RUO), providing researchers with a reliable and efficient tool to advance their understanding of EGFRvIII and its role in cancer.
In summary, the RUO Anti-EGFRvIII Antibody (AMG-595) is a cutting-edge biotech product with a clear biological function, wide range of applications, and promising results in experimental use cases. Whether you are studying EGFRvIII in cancer or looking for a potential therapy, this antibody is a valuable addition to your research arsenal. Order now and take your cancer research to the next level.
There are no reviews yet.